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Brief Definitive Report 
METABOLISM OF FORMYCIN B BY LE ISHMANIA  
AMASTIGOTES IN V ITRO 
Comparat ive Metabolism in Infected and Uninfected Human 
Macrophages* 
BY JONATHAN D. BERMAN,* PETRIE RAINEY, ~ AND DANIEL V. SANTI § 
From the *Department ofParasitology, Walter Reed Army Institute of Research, Walter Reed 
Army Medical Center, Washington, D. C. 20012; and the ~Departments of Biochemistr 7 and 
Biophysics and Pharmaceutical Chemistry, and the Division of Clinical Pharmacology, 
Department of Medicine, University, of California, San Francisco, California 94143 
Leishmaniasis initiated when sandflies inject the extracellular promastigote 
form of the parasite into the skin. Promastigotes are rapidly phagocytized, after 
which they transform into the intracellular amastigote form. The multiplication 
of the latter within macrophages leads to clinical disease. Treatment of leishman- 
iasis is primarily with pentavalent antimonials, parenteral and potentially toxic 
drugs with a 10-25% failure rate. The inosine analogue formycin B (FOB) 
inhibits multiplication of promastigotes (1-3) and is leishmanicidal to both 
antimony-sensitive and antimony-resistant amastigotes within human macro- 
phages in vitro (4). FoB is also leishmanicidal to Leishmania donovani amastigotes 
in infected hamsters after either intraperitoneal (1) or oral administration (J. D. 
Berman et al., Exp. Parasitol. In press). Biochemical studies of the metabolism of 
FoB in promastigotes revealed that this compound is initially converted to its 5'- 
nucleotide, formycin B 5'-monophosphate (FoB-MP), which is subsequently 
metabolized to adenosine nucleotide analogues of formycin A (FoA) that become 
incorporated into RNA (2, 3). The FoA nucleotides or FoA incorporation into 
RNA are believed to be responsible for the cytotoxic effects of FoB towards 
promastigotes. 
The present study was undertaken to determine the metabolism and mecha- 
nism of action of FoB in amastigotes within cultured human macrophages, a 
model that is comparable to the clinical situation. In addition, the metabolism of 
FoB in uninfected human macrophages and in free amastigotes was investigated. 
Materials and Methods 
Mono-dispersed Leishmania mastigotes of cutaneous strains WR 401 (Iran), WR 227 
and WR 420 (Panama), and WR 338 (Dominican Republic) were obtained from foot pads 
* Supported in part by grants to D. V. S. from the UNDP/World Bank/WHO Special Programme 
for Research and Training in Tropical Diseases and the Rockefeller Foundation. P. R. received 
partial support from U. S. Public Health Service (USPHS) training grant GM 07546. 
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of infected BALB/c mice (5). Human macrophages were derived from monocytes of 
peripheral blood of normal volunteers by 6 d of in vitro cultivation as monolayers in 2- 
cm ~ plastic wells and infected as previously described (5). To infect macrophages, ~ 1.5 
X 10 b mono-dispered amastigotes were added to each culture well, which contained ~ 105 
macrophages. After 4 h at 35°C, cultures were washed twice with 1 ml of Hank's buffered 
saline solution (HBSS; Gibco Laboratories, Grand Island, NY) to remove nonphagocytized 
parasites. Specified concentrations of [SH]FoB (1.9 Ci/mmol; ICN Pharmaceuticals) were 
added in 1 ml of medium consisting of RPMI 1640 (Gibco Laboratories) with 50 U/ml 
penicillin, 50 #g/ml streptomycin, and 10% heat-inactivated fetal calf serum. Infected 
and noninfected cultures were maintained at 35 °C in the presence of [SH]FoB for specified 
times after which the media was aspirated and the monolayer of cells was washed four 
times with 1 ml HBSS at ambient emperature. Each experiment utilized 11 wells, one of 
which was used to count the number of organisms and/or macrophages after Wrights/ 
Giemsa staining (5). The other wells in an experimental group were processed in a cold 
room as follows: The HBSS in one well was aspirated and replaced with 0.6 ml of 0.6 M 
trichloroacetic a id (TCA) and the macrophages were scraped into the acid. The HBSS 
in the second well was aspirated, the TCA suspension from the first well was added, and 
the macrophages were again scraped into the acid. This process was repeated until all 
macrophages within an experimental group were obtained in a single TCA suspension. 
To insure complete recovery, the entire process was repeated with 0.1 ml cold TCA 
which was then combined with the first suspension. The suspension was centrifuged at 
10,000 g for 1 min (0°C). The supernatant was neutralized by extraction with tri-n- 
octylamine in Freon 113 (7); the acid-insoluble fraction was washed with three 0.1-ml 
portions of 0.3 M TCA (0°C) and once with 0.2 ml of 95% EtOH (-20°C). For 
experiments with mono-dispersed amastigotes, 1.2 X 10 s cells (strain 227) were incubated 
for 16 h at 35°C in 6 ml of culture medium that contained 0.2 uM [SH]FoB. After the 
cells were harvested by centrifugation a d washed with HBSS, acid-soluble and -insoluble 
fractions were prepared (2). Analyses of the metabolites of FoB and of the incorporation 
of FoA into RNA were performed as previously described (2). 
Results 
When human macrophages infected with Leishmania strain 401 were incubated 
for 8 h with 0.2 #M [~H]FoB, high performance liquid chromatography (HPLC) 
analysis of  the acid-soluble xtract gave four radioactive peaks in addition to FoB 
(Fig. 1). These peaks were identified as FoB-MP, FoA-MP, FoA-DP, and FoA- 
TP, the latter being the predominant metabolite. The  same metabolites were 
found in uninfected macrophage controls, but they were present in significantly 
lower amounts (Fig. 1). 
Fig. 2 shows the kinetics of  accumulation of  FoB metabolites in both infected 
and uninfected macrophages over a 20-h period of exposure to 0.2 #M [3H]FoB. 
With infected cells, the nucleotide metabolites accumulated to maximal levels 
within 4-8  h and showed a slight decrease after 20 h of exposure. Throughout  
the period, FoA was progressively incorporated into RNA. No incorporation of  
radioactivity into DNA could be detected. The  pattern of  FoB metabolism was 
similar in uninfected cells except for the much lower level of metabolites 
throughout the period of exposure (Fig. 2B). 
Human macrophages infected with a number of  Leishmania strains were 
exposed to 0.04 and 0.2 #M [3H]FoB for 16 h. These concentrations correspond 
to the ECs0 and EC90 values for elimination of  amastigotes from infected mac- 
rophages after 6 d (4). Mono-dispersed amastigotes were also exposed to 0.2 uM 
[~H]FoB and uninfected macrophages were exposed to 0.2 #M and 10 uM [~H] 
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F]GtJRE 1. HPLC of FoB metabolites in acid-soluble extracts from 1.25 x 105 macrophages 
infected with ~ 1.25 x 105 Leishmallia amastigotes (strain WR 401) (open bars) and 1.25 x 
105 uninfected macrophages (solid bars), after an 8-h exposure to 0.2 #M [~Hl-formycin B.
The metabolites were separated on a Partisil SAX column (4.6 X 250 ram) as previously 
described (2). The histograms indicate the radioactivity ineach 3.0-ml fraction. 
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FoB. The  latter represents the ECs0 for cytolysis of  uninfected macrophages 
after 6 d (4). Table I shows the total FoA nucleotides present in cell extracts 
expressed as pmol per 106 macrophages or amastigotes; where measured, the 
amount of FoA incorporated into RNA is also provided. The  pertinent results 
derived from these experiments are as follows: First, when infected macrophages 
were exposed to 0.2 uM FoB there was an excellent linear correlation (r 2 = 
0.977) between the total number  ofamast igotes in the macrophage cultures (i.e., 
parasite burden) and the amount  of FoA nucleotides formed. Second, free 
amastigotes synthesized FoA nucleotides from FoB in a manner  similar to infected 
macrophages. Although the levels of  metabolites may be artifactually low because 
the obligate intracel]ular organisms were in an unnatural environment,  the 
experimental  confirms that the metabolites are indeed formed by the amastigotes. 
Third,  the amount of FoA metabolites in the intracellular amastigotes was 
correlated with the concentration of FoB to which the infected macropbages 
were exposed. At 0.2 ~M FoB, the levels of  FoA metabolites in amastigotes were 
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FIGURE 2. Accumulat ion  o f  fo rmyc in  metabo l i tes  in (A) macrophages  in fected with Leish- 
ma, ia  amast igotes  (strain WR 401) and  (B) un in fected macrophages  dur ing  t reatment  with 
0.2 #M [SH]-formycin B. Metabo l i te  levels were  determined  by HPLC as in Fig. 1. FoA 
incorporat ion  into RNA was determined  as prev ious ly  descr ibed (2). A FoB-MP; ~7, FoA-MP; 
l-q, FoA-DP;  (3, FoA-TP ;  O, FoA incorporat ion  into RNA.  
TABLE I 
Formycin A metabolites and incorporation i to RNA in infected and uninfected macrophages and 
in free a mastigotes* 
FoB concen- Parasite 
Experimental group tration burden 
FoA nucleotides RNA incorporation 
Macro- Amasti- Macro- Amasti- 
phages gotes phages gotes 
Macrophages infected 
with: 
strain 420 
strain 338 
strain 227 
strain 420 
strain 401 
strain 227 
strain 338 
Free amastigotes 
Uninfected macro- 
phages 
Uninfected macro- 
phages 
a m a stigotes 
per macro- pmol / lO  n pmol / lO  6 pmol / lO  6 pmol / lO  6 
~'Vl phage cells cells cells cells 
(average) 
0.04 2 4.1 2.1 0.72 0.36 
0.04 7 5.5 0.8 --* --* 
0.2 I 4.1 3.2 1.00 0.95 
0.2 2 8.9 4.2 2.49 1.22 
0.2 3 25.6 8.2 - -*  - -*  
0.2 5 36.7 7.2 - -*  --* 
0.2 7 62.5 8,8 --* --* 
0.2 - -  - -  1.4 - -*  --* 
0.2 - -  0.9 i - -  0.05 t - -  
10.0 - -  22.0 ! - -  1.10 ! - -  
'~ Cells were exposed to [SH]FoB for 16 h. Parasite burden was determined by counting the number of amastigotes 
in 100 macrophages and dividing by 100. The levels of radiolabeled metabolites and incorporation into RNA 
were determined as described in Materials and Methods. FoA nucleotides refers to the sum of FoA-MP, FoA-DP 
and FoA-TP. Levels of metabolites in amastigotes were determined by subtracting metabolite l vels in uninfected 
controls from the levels in infected macrophages and dividing by the parasite burden. 
* Not determined. 
! Average of four determinations. 
! Average of two determinations. 
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three- to fivefold higher than when 0.04 ~M FoB was used. Likewise, the amount 
of FoA metabolites in uninfected macrophages was dose-related: the levels of 
metabolites in cells treated with 10 ~M FoB were "-~25-fold higher than in 
macrophages treated with 0.2 #M FoB. Last, and perhaps most important, the 
amount of FoA metabolites that were formed in uninfected macrophages was 
far less than that formed in infected macrophages, or even in individual amasti- 
gotes. 
Discussion 
The results described here demonstrate that Leishmania mastigotes within 
cultured human macrophages metabolize FoB in the same manner as do extra- 
cellular promastigote forms (2, 3). The nucleoside isconverted to FoB-MP, FoA- 
MP, FoA-DP, and FoA-TP, the latter representing -~70% of the total metabo- 
lites; further, FoA is incorporated into RNA. No other metabolites were observed 
nor was incorporation into DNA detectable. There was an excellent correlation 
between the parasite burden and the amount of FoA metabolites formed, 
indicating that the intracellular parasites are responsible for the metabolic 
conversions. In promastigotes, the anti-leishmanial activity of FoB has been 
associated with its conversion to cytotoxic nudeotides of FoA or incorporation 
of FoA into RNA or both (2, 3). The experiments described here correlate the 
killing of amastigotes within macrophages with the synthesis of FoA nucleotides. 
That is, the levels of FoA nucleotides formed in amastigotes and the efficacy of 
FoB in eliminating the organisms within macrophages are both related to the 
concentration of the drug used. 
It has been reported that FoB is not phosphorylated in mammalian cells (8) 
and is remarkably nontoxic in animals (9). We show here that uninfected 
macrophages do in fact metabolize FoB in a manner qualitatively similar to that 
of Leishmania. However, at levels of FoB necessary to eliminate amastigotes from 
infected macrophages, the amount of metabolites formed in uninfected macro- 
phages is low, and the drug has no visibly apparent deleterious effects on the 
macrophages. When concentrations of FoB (10 #M) were used that were 50-fold 
higher than the ECg0 for elimination of amastigotes, ignificant levels of FoA 
metabolites were formed in uninfected macrophages; at this concentration, 
~50% of the macrophages undergo cytolysis after a 6-d exposure to the drug. 
Although we have not yet determined the extent o which other cells are affected 
by FoB, these results with infected human macrophages suggest that a sufficient 
therapeutic index exists to warrant serious consideration of FoB as an anti- 
leishmanial agent in humans. 
Summary 
Formycin B is metabolized by cutaneous Leishmania amastigotes within cul- 
tured human macrophages to give formycin B 5'-monophosphate and formycin 
A 5'-mono-, di-, and triphosphates. Formycin A is also incorporated into RNA. 
The activity of formycin B against amastigotes was correlated with the levels of 
formycin A metabolites formed in the parasites. Uninfected macrophages also 
convert formycin B into the same products, but the levels are markedly lower 
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than those seen in infected macrophages. The  results suggest hat a sufficient 
therapeutic index exists to warrant consideration of  formycin B as an anti- 
leishmanial drug in humans. 
We thank L. S. Lee for excellent technical assistance. 
Received for publication 6 April 1983. 
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